香草醛异■唑衍生物的设计合成及杀菌活性

为了寻找结构新颖、杀菌活性更好的绿色农药。选用天然产物香草醛作为基本原料,引入五元杂环异■唑结构,首次设计并合成了28个香草醛异■唑类衍生物。结构经核磁共振氢谱、碳谱及高分辨质谱分析确认。测试了所有目标衍生物对烟草灰霉病菌(Botrytis cinerea)、层出镰刀菌(Fusarium proliferatum)、木贼镰刀菌(Fusarium equiseti)、玉米圆斑病菌(Bipolaris zeicola)、胶胞炭疽菌(Colletotrichum gloeosporioides)、草茎点霉菌(Phoma herbarum)6种广谱菌的杀菌活性。杀菌活性测定结果显示：在50μg/mL质量浓度下,部分化合物对6种真菌的菌丝生长均具有一定抑制作用,2-甲氧基-4-(5-苯基异■唑-3-基)苯乙酸酯对6种真菌的抑菌活性整体良好,对玉米圆斑病菌等3种菌的抑菌活性超过对照组百菌清;2-甲氧基-4-(5-(4-乙基苯基)异唑-3-基)苯酚对烟草灰霉病菌的抑菌活性最高,抑菌率可以达到93%。初步构效关系表明,对活性片段香草醛上的酚羟基进行乙酰化衍生,有助于提高化合物对6种病原菌的抑菌活性,为...     

水杨醛缩3-(5-取代苯基-1,3,4-(噁)二唑-2-亚甲硫基)-5-吡啶-3-基-1,2,4-三唑-4-胺席夫碱的合成及抗菌活性

3-(5-取代苯基-1,3,4-噁二唑-2-亚甲硫基)-5-吡啶-3-基-1,2,4-三唑-4-胺与水杨醛缩合制得相应的席夫碱类化合物,其结构经MS、IR、1HNMR和元素分析确证。用试管稀释试验法研究了目标化合物的体外抑菌活性,结果表明多数化合物在体外表现出较好的抑菌活性。     

3-(3,4-亚甲基二氧苯基)-5-苯基异噁唑啉的合成

以3,4-亚甲基二氧苯甲醛为起始原料,经缩合、氯化和1,3-偶极环加成三步反应合成3-(3,4-亚甲基二氧苯基)-5-苯基异噁唑啉(3),其中第一、二步反应分别得到相应的肟(1)和氯代肟(2),第三步经氯代肟与三乙胺反应生成的腈氧化合物再与苯乙烯发生1,3-偶极环加成生成异噁唑啉。研究了三乙胺的用量和反应温度对反应的影响,在较好条件下,以氯代肟为基准,第三步1,3-偶极环加成得3-(3,4-亚甲基二氧苯基)-5-苯基异噁唑啉(3)的收率为92%。     

含嘧啶环的新型异噁唑甲酰基脲的合成及生物活性研究

以5-甲基-3-异噁唑甲酰胺、草酰氯和4,6-二取代嘧啶为原料,经两步反应合成了5种N-(4,6-二取代嘧啶)-5-甲基-3-异噁唑甲酰基脲新化合物,其结构经1H NMR、IR和元素分析确证。初步测试了目标化合物对马唐和苘麻等田地杂草的杀除活性,结果表明,部分化合物对马唐有较好的抑制活性。     

两种含吡唑基1,3,4-噁二唑衍生物的合成及光谱性质

以苯乙酮为起始原料,与草酸二乙酯、水合肼反应得到5-苯基-1H-吡唑-3-甲酸乙酯,再通过亲核取代反应、酯的肼解反应和合环反应,得到5-(1-苯甲基-3-苯基-1H-吡唑-5-基)-2-硫基-1,3,4-噁二唑,在碳酸钾催化下,进一步与对甲基溴化苄发生亲核取代反应得到5-(1-苯甲基-3-苯基-1H-吡唑-5-基)-2-(4-甲基苯甲基-2-硫基)-1,3,4-噁二唑。所有中间体及目标化合物的结构均经核磁共振、红外光谱、元素分析表征,并对目标化合物的紫外吸收光谱和荧光光谱性质进行了初步研究。     

来氟米特异构体的合成研究

以5-甲基异噁唑-4-甲酸(1)为起始原料,经酰氯化得5-甲基-4-异噁唑甲酰氯(2),2与三氟甲基苯胺(3)缩合反应,得来氟米特异构体(4),最后经氢氧化钠水解,得水解产物5,纯度98%,收率为74%~85%。所合成的化合物经熔点和质谱分析确证,为来氟米特质量控制提供依据。     

2-(N-苯磺酰基吲哚-3-基)-3-N-酰基-5-苯基-1,3,4-噁唑啉类化合物抑菌活性研究

为了研究2-(N-苯磺酰基吲哚-3-基)-3-N-酰基-5-苯基-1,3,4-噁唑啉类化合物中具有潜在应用价值的抑菌先导化合物。在0.1 g/L质量浓度下,采用菌丝生长速率法测定了14种2-(N-苯磺酰基吲哚-3-基)-3-N-酰基-5-苯基-1,3,4-唑啉类化合物对小麦赤霉病菌、白菜黑斑病菌、棉花枯萎病菌、水稻稻瘟病菌和烟草赤星病菌的室内抑菌活性。结果表明,化合物1~化合物14对所测5种植物病原菌均表现出不同程度的抑菌活性,其中化合物9和化合物14对小麦赤霉病菌、白菜黑斑病菌、棉花枯萎病菌、水稻稻瘟病菌和烟草赤星病菌5种植物病原菌活性较好,其抑制率分别为15.69%~31.08%和16.28%~29.41%,表现出一定的广谱抑菌活性。初步拟定将这2个化合物作为进一步衍生修饰的先导化合物。     

基于1,3-偶极环加成的新型螺[吲唑-异噁唑]衍生物合成及表征

以1-苯基-6,7-二氢-1H-吲唑-4(5H)-酮和取代芳香醛为原料,在碱性条件下缩合得到5-芳亚甲基-1-苯基-6,7-二氢-1H-吲唑-4(5H)-酮,再与腈氧化物进行1,3-偶极环加成得到系列4'-(4-芳基)-3'-(2,6-二氯苯基)-1-苯基-6,7-二氢-4'H-螺[吲唑-5,5'-异噁唑]-4(1H)-酮新化合物,采用NMR、IR、MS以及元素分析表征其结构。     

苯联三唑(磺)酰胺衍生物的合成及抑菌活性

[目的]寻找新杀菌活性的苯联三唑(磺)酰胺衍生物。[方法]设计合成了系列N-(4-(3-苯基-1H-1,2,4-三唑-1-基)苯基)苯磺酰胺或苯甲酰胺衍生物,以菌丝生长速率法对其抑菌活性进行了初步评价。[结果]合成了3类12个N-(4-(3-苯基-1H-1,2,4-三唑-1-基)苯基)苯磺酰胺或苯甲酰胺衍生物,结构经1H及13C NMR确证。[结论]目标化合物收率为60.7%～81.3%;该类化合物对番茄灰霉病菌有较强抑制作用,其中11个化合物的抑菌率均大于85%,优于对照药剂烯唑醇(80.8%);5个化合物对苹果腐烂病菌的抑菌率大于74%,优于烯唑醇(68.6%)。     

伊索昔康的合成方法研究

研究并合成一种昔康类非甾体抗炎药——4-羟基-2-甲基-N-(5-甲基-3-异噁唑基)-2H-1,2-苯并噻嗪-3-羧酰胺-1,1-二氧化物(伊索昔康).以糖精钠(1)和氯乙酸甲酯为原料,经取代、重排扩环、甲基化反应生成4-羟基-2-甲基-2H-1,2-苯并噻嗪-3-羧酸甲酯1,1-二氧化物(4)中间体,化合物(4)与5-甲基-3-异噁唑胺发生酰胺化反应生成伊索昔康(5).目标产物总收率为64.6％,纯度达100％,其结构由1H-NMR和MS表征.     

Synthesis and antibacterial activity of some quinazolin containing oxadiazolin-5-thione moieties

Several new quinazolin-4-one containing oxadiazolin-5-thione moieties were synthesized and evaluated for their antibacterial activity. Esterification of 2-substituted phenyl-3-carboxyalkyl-methyl-3,4-dihydroquinazolin-4-ones (I) with absolute ethyl alcohol in the presence of sulfuric acid afforded the corresponding esters (II). Hydrazinolysis of (II) with hydrazine hydrate in ethanol gave the acid hydrazides (III). Refluxing (III) with equimolar amounts of potassium hydroxide and slight excess of carbon disulfide afforded the corresponding oxadiazolin-5-thione derivatives (IV). The thiones undergo Mannich reaction using a formaldehyde/secondary amines mixture whereby the 4-substituted amino-methyl derivatives (V) were obtained. Microanalysis, IR, NMR spectra were used to elucidate the structures of the newly synthesized compounds. All the designed compounds were tested for their antibacterial activity. The morpholino derivatives showed an encouraging antibacterial activity.     

1-(5-甲基-1,3,4-噻二唑基)-3-苯基硫脲的合成及抑菌实验研究

以四丁基溴化铵为催化剂、5-甲基-2-氨基-1,3,4-噻二唑和苯异硫氰酸酯为原料,在乙腈溶剂中合成了1-(5-甲基-1,3,4-噻二唑基)-3-苯基硫脲,确定了优化的工艺条件,并对产物的抑菌活性进行了初步研究.     

芳基取代的3-羧基-5-氧代-四氢呋喃衍生物的合成

以丁二酸酐和取代的苯甲醛为原料，用氯化锌一三乙胺为催化剂合成各种2-（取代）苯基-3-羧基-5-氧代四氢呋喃衍生物，并对各种反应条件进行了探讨。     

Cyclopenta[d]pyrimidines and dihydropyrrolo[2,3-d]pyrimidines as potent and selective corticotropin-releasing factor 1 receptor antagonists

Two new classes of potent and selective CRF(1) receptor antagonists are presented. Exploration of general templates 3 and 4 through modifications of the top amine and bottom phenyl substituents led to optimization of the in vitro affinity and pharmacokinetic profiles. The typical alkyl chains present in the top region of CRF(1) antagonists were replaced by substituted heteroaryl moieties, leading to a dramatic improvement of the metabolic stability. This improvement was apparent when the compounds were dosed in vivo: several compounds exhibited low plasma clearance, good oral bioavailability, and high brain penetration. As a consequence of their outstanding pharmacokinetic profiles, these CRF(1) antagonists, as exemplified by compound 4 fi (4-(4-bromo-3-methyl-1H-pyrazol-1-yl)-7-(2,4-dichlorophenyl)-2-methyl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine), produced a dose-dependent "anxiolytic-like" effect when administered orally, decreasing the vocalization of rat pups.     

杀菌剂唑菌酯的创制经纬

概述了运用中间体衍生化方法发现杀菌剂唑菌酯(SYP-3343)的过程:以取代吡唑环替换丁香菌酯结构中的香豆素环,设计并合成了一系列化合物,发现先导化合物(2),通过优化研究发现多个高活性化合物,最终发现了(E)-2-(2-((3-(4-氯苯基)-1-甲基-1H-吡唑-5-基氧基)甲基)苯基)-3-甲氧基丙烯酸甲酯,即唑菌酯(SYP-3343),其具有广谱的杀菌活性,对蔬菜和作物的多种病害如霜霉病、稻瘟病、白粉病、炭疽病等均有很好的防治效果,同时SYP-3343具有明显的杀虫、杀螨活性,可达到病虫兼治之目的。已于2009年获准临时登记。     

Einfluß von Schwefelverbindungen auf die Inhibition der Thermooxidation von Polypropylen

The influence of mixtures of substituted phenols with sulphur compounds on the thermooxidative stability of polypropylene was studied. Following substituted phenols were used: 4,4′-butylidene-bis(3-methyl-6-tert.-butylphenol), 2,2′-methylidene-bis(4-methyl-6-tert.-butylphenol) and 4,4′-thio-bis(3-methyl-6-tert.-butylphenol). As sulphur compounds phenylalkylsulphides, p-nitrophenylalkylsulphides and some other p-substituted phenylsulphides were used. The effect of these mixtures was studied at 180°C in oxygen atmosphere.     

4-（4-二甲氨基）苯基-6-甲基-5-乙氧羰基-3,4-二氢嘧啶-2-酮的合成

采用氨基磺酸作催化剂,无水乙醇作溶剂,对二甲氨基苯甲醛、乙酰乙酸乙酯和脲在加热搅拌条件下回流反应3 h,合成了4-（4-二甲氨基）苯基-6-甲基-5-乙氧羰基-3,4-二氢嘧啶-2-酮,产率为78.5%。     

3-取代苯基-5-羟基-5-三氟甲基异噁唑啉的合成

3 取代苯基 5 羟基 5 三氟甲基异口恶唑啉是合成具有异口恶唑结构的原卟啉原氧化酶抑制剂类除草剂的重要中间体。通过以下途径制得4个具有不同取代基的异口恶唑啉中间体:首先,在回流状态,n(甲醇钠)∶n(取代苯乙酮)=2∶1的甲醇钠存在下,取代苯乙酮与三氟乙酸乙酯缩合得到取代苯基 4,4,4 三氟 1,3 丁二酮;后者可在室温下,于二氯甲烷溶剂中,用氯化硫酰氯化,在侧链上引入氯原子;最后,以乙酸作溶剂,回流下,具有不同取代基的苯基 1,3 丁二酮与盐酸羟胺闭环得到产物。反应总收率大于95%。产品结构经质谱、核磁共振氢谱、碳谱确认正确。     

Synthesis and antimicrobial evaluation of some pyrazolo-thiazolyl alkoxy-1H-isoindole-1, 3(2H)-dione derivatives

1,3-Thiazolidine-2,4-dione 2 has been synthesized by the cyclisation reaction of thiourea and chloroacetic acid in the presence of ethanol. The reaction of compound 2 with substituted aromatic aldehyde afforded the corresponding derivatives of substituted 5-benzylidene-1,3-thiazolidinone-2,4-dione 3a–d, which upon reflux with ω-bromoalkoxyphthalimide gave 2-{[-5-(substituted benzylidine)-2,4-dioxo-1,3-thiazolidine-3-yl]alkoxy} -1H-isoindole-1,3(2H)-dione 4a–i. Further, compounds 4a–i were treated with phenyl hydrazine and 2,4 dinitro phenyl hydrazine in the DMF to yield the title compound 2-[5-oxo-2,3-substituted diphenyl-2H-pyrazolo[3,4-d][1,3]thiazol-6(5H)-yl)alkoxy]-1H-isoindole-1,3(2H)-dione 5a–r. Structures of newly synthesized compounds were established based on elemental analysis, IR, ¹H NMR and mass spectral data. Synthesized compounds have been assayed for their antibacterial activities against B. subtilis, K. pneumoniae, P. aeruginosa and S. aureus and antifungal activities against A. fumigatus and C. albicans.     

New Bioactive Fused Triazolothiadiazoles as Bcl-2-Targeted Anticancer Agents

A series of 3-(6-substituted phenyl-[1,2,4]-triazolo[3,4-b]-[1,3,4]-thiadiazol-3-yl)-1H-indoles (5a–l) were designed, synthesized and evaluated for anti-apoptotic Bcl-2-inhibitory activity. Synthesis of the target compounds was readily accomplished through a reaction of acyl hydrazide (1) with carbon disulfide in the presence of alcoholic potassium hydroxide to afford the corresponding intermediate potassium thiocarbamate salt (2), which underwent cyclization reaction in the presence of excess hydrazine hydrate to the corresponding triazole thiol (3). Further cyclisation reaction with substituted benzoyl chloride derivatives in the presence of phosphorous oxychloride afforded the final 6-phenyl-indol-3-yl [1,2,4]-triazolo[3,4-b]-[1,3,4]-thiadiazole compounds (5a–l). The novel series showed selective sub-micromolar IC₅₀ growth-inhibitory activity against Bcl-2-expressing human cancer cell lines. The most potent 6-(2,4-dimethoxyphenyl) substituted analogue (5k) showed selective IC₅₀ values of 0.31–0.7 µM against Bcl-2-expressing cell lines without inhibiting the Bcl-2-negative cell line (Jurkat). ELISA binding affinity assay (interruption of Bcl-2-Bim interaction) showed potent binding affinity for (5k) with an IC₅₀ value of 0.32 µM. Moreover, it fulfils drug likeness criteria as a promising drug candidate.